Bank of New York Mellon Corp
BankPosition in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1390777
NEW YORK, NY
Position in MRVI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,229,856
+$1,257,348 QoQ
Shares Held
357,349
+4.0% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 177 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. MRVI ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,229,856 | 357,349 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $972,508 | 343,643 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,087,735 | 334,688 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $969,777 | 337,902 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $836,820 | 347,229 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $650,284 | 294,247 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,718,348 | 315,294 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $3,317,632 | 399,234 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,625,914 | 506,413 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,375,165 | 389,293 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $2,677,585 | 408,792 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $5,151,230 | 515,123 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $6,283,749 | 505,531 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $8,479,536 | 605,249 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $8,561,642 | 598,298 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $14,071,519 | 551,176 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $16,720,333 | 588,537 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,694,078 | 416,617 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $17,190,646 | 410,278 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $17,703,939 | 360,716 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $11,411,568 | 273,462 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $5,760,492 | 161,630 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||